Visceral adipose tissue and body fat mass: Predictive values for and role of gender in cardiometabolic risk among Turks
To access this article, please choose from the options below
The Turkish Adult Risk Factor survey 2006–2008 was supported by the Turkish Society of Cardiology and the pharmaceutical companies SanofiAventis, Pfizer, Novartis, and AstraZeneca, Istanbul, Turkey.
PII: S0899-9007(09)00240-8
doi:10.1016/j.nut.2009.05.019
© 2010 Published by Elsevier Inc.
